Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
By Jahnavi Nidumolu and Krystal Hu (Reuters) -Twitter’s cash flow remains negative because of a...
MOSCOW (Reuters) – President Vladimir Putin said Russia had a “sufficient stockpile” of cluster bombs...
(This July 15 story has been refiled to fix typographical errors in paragraphs 3 and...
By Yew Lun Tian BEIJING (Reuters) – A Chinese naval flotilla set off on Sunday...
By Stephen Nellis, Andrea Shalal and Karen Freifeld (Reuters) – The chief executives of Intel...
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...
By Sheila Dang and Krystal Hu (Reuters) -Elon Musk on Friday said the purpose of...
(Corrects 2nd paragraph to make it “June 2022” instead of “last month”) By Curtis Williams...
By Jody Godoy (Reuters) -Ripple Labs Inc did not violate federal securities law by selling...